<DOC>
	<DOCNO>NCT00270075</DOCNO>
	<brief_summary>The purpose study determine whether epoetin alfa enable self-donation least 4 unit blood 2-week period surgery ( short period time conventional 3-week blood donation period surgery ) patient anemic undergoing orthopedic heart blood vessel surgery . Epoetin alfa genetically engineer protein stimulates red blood cell production .</brief_summary>
	<brief_title>A Study Determine Safety Effectiveness Epoetin Alfa Facilitating Self-donation Blood Before Surgery Patients Who Are Not Anemic Who Will Undergoing Orthopedic Heart Blood Vessel Surgery</brief_title>
	<detailed_description>Patients undergo orthopedic heart blood vessel surgery frequently require blood transfusion operation . Patients often blood collect purpose standard 3- 4-week period surgery . A large percentage patient able pre-deposit blood transfusion . For patient , agent facilitate self-donation reduce need transfusion others less time conventional 3 week surgery may improve overall safety surgery . This randomized , double-blind , placebo-controlled , parallel group , multicenter study evaluate whether epoetin alfa enable self-deposit least 4 unit blood abbreviate presurgical time period 2 week patient anemic undergoing orthopedic heart blood vessel surgery . The study consist 7-day screening period patient test eligibility study , 14-day treatment blood collection period , follow-up evaluation period begin 1 day surgery continue study termination visit perform patient 's discharge hospital surgery . Eligible patient randomly assign one four treatment group : epoetin alfa 300 units/kilogram ( U/kg ) , epoetin alfa 600 U/kg , placebo match volume epoetin alfa 300 U/kg , placebo match volume epoetin alfa 600 U/kg , give injection vein . Twice many patient receive treatment epoetin alfa receive treatment placebo . A total 3 dos study medication administer patient , one dose give Days 1 , 4 , 7 study . Additionally , Day 1 Day 14 study , patient receive 200 milligram iron 5 milligram folate supplement daily mouth support red blood cell generation . On Day 1 , first dose study drug , one unit blood collect patient store self-donated blood transfusion . An additional unit blood collect patient ( administration study drug ) store self-donated blood transfusion Days 4 , 7 , 11 , 14 , patient 's hemoglobin level &gt; 11.0 g/dL ; patient 's hemoglobin level &lt; =11.0 g/dL day , blood collect day , although study drug give . A maximum 5 unit blood collect patient . If sufficient unit plan surgery collect , preparation make patient receive need unit blood donor . The study duration 14 day , end surgery . Safety evaluation include laboratory test , vital sign , report incidence adverse event . Effectiveness evaluate compare number self-donated unit blood collect within 2 week , change hemoglobin level among different treatment group start study end study . The study hypothesis abbreviate ( 2-week ) period surgery , epoetin alfa facilitate collection least 4 unit self-donated blood patient anemic undergoing orthopedic heart blood vessel surgery . Epoetin alfa 300 units/kilogram ( U/kg ) , epoetin alfa 600 U/kg , placebo matching volume 300 U/kg dose , placebo matching volume 300 U/kg dose , injection vein ; give Days 1 , 4 , 7 study .</detailed_description>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Patients schedule orthopedic heart blood vessel surgery requirement 3 unit blood nonanemic ( hemoglobin within normal range 12.0 18.0 grams/deciliter ) laboratory test within normal range Patients history primary blood disease sign symptom significant disease/dysfunction , sign symptom significant heart blood vessel disease ( patient undergo orthopedic surgery ) severe alteration rhythm heartbeat , persistent brief attack chest pain , significant heart failure heart unable maintain adequate circulation blood ( patient undergo heart blood vessel surgery ) uncontrolled high blood pressure sign symptom significant dizziness , faintness , lightheadedness appear stand cause low blood pressure receive blood transfusion within 1 month start study body weight great 100 kilogram ( approximately 220 pound )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>epogen</keyword>
	<keyword>erythropoietin</keyword>
	<keyword>orthopedic procedure</keyword>
	<keyword>orthopedic surgery</keyword>
	<keyword>cardiovascular surgical procedure</keyword>
	<keyword>Blood transfusion</keyword>
	<keyword>epoetin alfa</keyword>
</DOC>